Argent Biopharma LtdASX: RGT

$250,000 in Funding Received under Financing Facility

· Issued by Argent BioPharma Ltd via ASX

Filed with ASX ·

11 August 2026 $250,000 in Funding Received under Financing Facility Argent BioPharma Ltd ( ASX: RGT ) ( Argent or the Company ) confirms that it has received A$250,000 in funding under the A$11 million convertible securities financing agreement with C/M Capital Master Fund, LP and...

View Attachment

6ix hasn’t read this filing yet.

Argent Biopharma Ltd on 6ix

Story so far

Earlier from Argent Biopharma

Later from Argent Biopharma

All Argent Biopharma news releases